FDAnews
www.fdanews.com/articles/97693-surgisis-biodesign-for-pelvic-floor-repair-now-anatomically-shaped-for-more-accurate-and-consistent-placement-during-surgery

Surgisis Biodesign for Pelvic Floor Repair Now Anatomically Shaped for More Accurate and Consistent Placement During Surgery

August 27, 2007

Cook Women’s Health, a division of Cook Medical, announced it introduced Surgisis Biodesign for anterior pelvic floor repair, a treatment that combines attributes of synthetic mesh and biologic grafts, the company said.

Pelvic floor repair is commonly used to treat pelvic organ prolapse. However, some current tissue repair methods may not provide a lasting solution for pelvic organ prolapse. Multiple procedures are often required to remove and replace the mesh or graft and subsequent scar tissue.

Surgisis Biodesign incorporates the “best attributes” of a biologic graft — resistance to infection and complete remodeling — with moderate price, Cook said. It communicates with the patient’s body, signaling surrounding cells to grow across the scaffold, allowing the body to restore itself. Unlike synthetic mesh and cross-linked biologic grafts, it is resistant to infection, encapsulation and erosion into surrounding tissue, it added.

Because Surgisis Biodesign helps the pelvic floor remodel itself naturally, the patient’s restored tissue functions normally within the body, the company said. Once the healing process is complete, Surgisis Biodesign is “undetectable and provides a permanent repair.” This reduces the need for multiple surgeries and allows patients to return to their normal activities.